Yasoo Health Report issue

For profit Phase 3
Founded: Johnson City TN United States (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2007
NCT01018303
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (4)

calcium (1 trial)

cyanocobalamin (berocca) (1 trial)

iron (1 trial)

multivitamins (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Avitaminosis (Phase 3)

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Inflammation (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4